Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
4
36%
Ph not_applicable
6
55%
Ph phase_3
1
9%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
4(36.4%)
N/ANon-phased studies
6(54.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(5)
Other(4)

Detailed Status

Completed5
unknown4
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (9.1%)
Phase 44 (36.4%)
N/A6 (54.5%)

Trials by Status

unknown436%
not_yet_recruiting218%
completed545%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11